Lupin informs about press release

17 Aug 2016 Evaluate

Lupin has informed about a Press Release dated August 17, 2016 titled ‘Lupin Receives FDA Approval for Potassium Chloride Extended-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2114.95 11.65 (0.55%)
02-Jan-2026 10:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.70
Dr. Reddys Lab 1245.90
Cipla 1509.70
Zydus Lifesciences 915.95
Lupin 2114.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×